Longxing Chemical Stock Co., Ltd.

SZSE:002442.SZ

5.19 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013201220112010200920082007
Revenue 4,355.4294,272.1584,560.1153,438.5392,295.7462,805.933,085.7372,702.2481,843.2981,737.0692,438.3222,344.4271,940.4472,043.2921,333.594967.993895.063626.939
Cost of Revenue 3,889.0423,862.714,162.8282,931.6821,968.9982,463.2132,574.532,203.1491,467.3521,487.3022,121.222,002.7681,627.9481,652.4841,079.518739.361691.315460.774
Gross Profit 466.387409.448397.287506.857326.748342.717511.207499.099375.946249.767317.101341.659312.499390.807254.076228.632203.748166.165
Gross Profit Ratio 0.1070.0960.0870.1470.1420.1220.1660.1850.2040.1440.130.1460.1610.1910.1910.2360.2280.265
Reseach & Development Expenses 38.60828.05927.6825.20713.96115.93818.40717.3914.41516.45517.1615.23715.59518.6131.134000
General & Administrative Expenses 73.72463.29758.2753.24830.86333.48842.78137.03644.22334.11534.23830.07528.76614.07618.52831.08636.57224.797
Selling & Marketing Expenses 16.45718.62527.70429.65521.434113.242121.698138.517145.925112.272123.515121.93114.562115.63984.51965.21564.94838.775
SG&A 90.18181.92285.97482.90352.297146.73164.479175.552190.148146.387157.753152.005143.327129.715103.04796.301101.5263.571
Other Expenses 174.3450119.912115.51492.55998.589112.841105.25621.7659.54815.58324.86418.04120.4239.4722.9441.5231.716
Operating Expenses 303.135274.786233.566223.625158.816261.258295.726298.198291.015250.7250.375242.614213.955196.395136.884103.399105.05565.852
Operating Income 163.252175.114170.895288.152193.248123.912159.074192.55531.846-103.78-6.5340.12828.971127.12675.69687.61139.21185.823
Operating Income Ratio 0.0370.0410.0370.0840.0840.0440.0520.0710.017-0.06-0.00300.0150.0620.0570.0910.0440.137
Total Other Income Expenses Net -2.049-48.822-30.238-64.439-72.223-39.203-40.758-71.194-35.703-63.093-76.827-72.883-49.431-32.863-21.88-28.016-33.9516.5
Income Before Tax 161.203126.292113.985195.07597.31322.955154.10774.14545.239-97.1138.70423.77146.166147.54984.95190.52739.344117.54
Income Before Tax Ratio 0.0370.030.0250.0570.0420.0080.050.0270.025-0.0560.0040.010.0240.0720.0640.0940.0440.187
Income Tax Expense 19.11715.8910.29423.44119.8583.73421.38624.52714.432-14.681-6.2994.8895.5423.78712.44221.2618.68613.676
Net Income 142.087110.402103.691171.63477.45619.221132.72149.95930.819-82.43215.00319.5144.047122.2372.5169.26630.658103.864
Net Income Ratio 0.0330.0260.0230.050.0340.0070.0430.0180.017-0.0470.0060.0080.0230.060.0540.0720.0340.166
EPS 0.290.230.220.360.160.040.280.10.064-0.170.0310.0410.090.250.170.190.0830.29
EPS Diluted 0.290.230.220.360.160.040.280.10.064-0.170.0310.0410.090.250.170.190.0830.29
EBITDA 312.005275.408258.343360.453261.327186.94328.576256.171216.035109.2215.534216.355201.773259.7157.465157.547104.485135.834
EBITDA Ratio 0.0720.0640.0570.1050.1140.0670.1060.0950.1170.0630.0880.0920.1040.1270.1180.1630.1170.217